News 8 has learned of additional facilities in North Texas that received pain medication from New England Compounding Pharmacy, the facility at the center of a nationwide meningitis outbreak.
The FDA on Monday made available the list of health care facilities that received recalled products from linked to tainted back pain injections.
A few hours later, the agency said it had "found some problems with the list" and the information was "inaccurate."
The FDA said it was working to correct the list.
Not every facility on the list initially provided by the agency received contaminated products, but all of them were sent some type of recalled medicine from the compounding pharmacy, including — we are learning for the first time — three facilities that treat children.
Here is the original list provided by the FDA, which is subject to revision:
- Children's Medical Center, Dallas
- Children's Medical Center at Legacy, Plano
- Cosmetic & Maxillofacial Surgery Center, Dallas
- Dallas Back Pain Management
- Dallas Plastic Surgery
- Dr. Douglas Lorimer, Fort Worth
- Mansfield Surgery Center
- Our Children's House at Baylor, Dallas
The FDA admits its list may not be complete. News 8 knows of two other medical facilities in North Texas that have received medicine from the New England Compounding Pharmacy:
Texas Health Southlake is monitoring more than 100 patients who got potentially contaminated injections. Medical City Dallas confirms they got medicine from the pharmacy now under investigation, although none of it was the suspect injections.
The FDA said clinics on its list need to double-check their stocks and stop using any products from NECP.
There is no federal order that a clinic be in touch with patients who used products that were part of the voluntary recall, but this list certainly narrows the possibilities for patients who may be concerned about if they have been exposed.